Literature DB >> 32888803

Allergen-Related Coronary Vasospasm "Kounis Syndrome" Requiring Administration of Epinephrine and a Coronary Vasodilator.

Ryosuke Shintani1, Motohiro Sekino2, Takashi Egashira3, Rintaro Yano3, Haruka Inoue4, Sojiro Matsumoto3, Ushio Higashijima3, Shuhei Matsumoto4, Tsuyoshi Yonekura5, Tetsuya Hara6.   

Abstract

Kounis syndrome is an anaphylactic reaction leading to acute coronary syndrome. The acute treatment of anaphylaxis is epinephrine; however, epinephrine may cause coronary vasoconstriction, reduce coronary blood flow, increase myocardial oxygen demand, and worsen myocardial ischemia. On the other hand, coronary vasodilation, a treatment for acute coronary syndrome, can aggravate hypotension in patients with anaphylaxis. Herein, the authors report a case of type II Kounis syndrome, with vasospasm in a patient with coronary disease, requiring the administration of epinephrine and a coronary vasodilator for resuscitation. The authors administered intravenous epinephrine continuously from lower dosages and performed delicate titration. The coronary vasodilator nicorandil, which has little effect on hemodynamics, also was administered. These treatments improved hemodynamics without complications. Circulatory management that considers both anaphylaxis and coronary lesions is crucial to improve prognosis in this syndrome.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Kounis syndrome; anaphylaxis; coronary vasospasm; epinephrine; nicorandil; therapeutic management

Mesh:

Substances:

Year:  2020        PMID: 32888803     DOI: 10.1053/j.jvca.2020.08.009

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  1 in total

1.  Anaphylactic shock in a patient with severe aortic stenosis treated with adrenaline and landiolol for circulatory management: A case report.

Authors:  Akihiro Yokoyama; Motohiro Sekino; Taiga Ichinomiya; Hironori Ishizaki; Keiko Ogami-Takamura; Takashi Egashira; Rintaro Yano; Sojiro Matsumoto; Ushio Higashijima; Tetsuya Hara
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.